Correction: Identifying Risk Factors for Hypoglycemia in Type 2 Diabetes
Background
Hypoglycemia is a significant concern in the management of type 2 diabetes mellitus (T2DM), affecting patient safety and treatment outcomes. Understanding the risk factors associated with hypoglycemia is crucial for preventing adverse events. This systematic review and meta-analysis aimed to identify these risk factors.
Data Highlights
No numerical or trial data is presented in the correction notice.
Key Findings
The correction addresses the omission of funding disclosure in the original article.
Type 2 diabetes mellitus is a prevalent metabolic disorder globally.
Hypoglycemia poses risks that necessitate careful management in T2DM patients.
Clinical Implications
Clinicians should be aware of the importance of funding disclosures in research to maintain transparency.
Conclusion
The correction emphasizes the need for accurate reporting in clinical research.
Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.
